论文部分内容阅读
Molecular signaling involving intrinsically disordered proteins in prostate cancer
【机 构】
：
Department of Pharmacy, Centro Interuniversitario di Ricerca sui Peptidi Bioattivi, University of Na
【出 处】
：
亚洲男性学杂志（英文版）
【发表日期】
：
2016年5期
其他文献
Gonadotropin therapy is commonly used to induce virilization and spermatogenesis in male isolated hypogonadotropic hypogonadism (IHH) patients.In clinical practice,5.6％-15.0％ of male IHH patients show poor responses to gonadotropin treatment;therefore,tes
Semen from 5210 sperm bank donors was analyzed and trends in semen quality were evaluated at Shandong Human Sperm Bank between 2008 and 2014. After 2–7 days of abstinence, semen samples were collected. Measurements of semen volume, sperm concentration, sp
No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer
Prior studies suggested that the use of androgen deprivation therapy (ADT) in patients with prostate cancer (PC) might cause the impairment of cognitive function which is one of the common symptoms of dementia; however, the association between ADT and cog
Advancement of male health is dependent upon updates to insurance coverage for infertility in the Un
The insurance environment in the United States has traditionally ignored fertility as a barometer of men\'s health.However,there is now growing evidence that male infertility is associated with multiple medical comorbidities including a variety of cardi
期刊
Dear Editor,rnCellular angiofibroma (CAF) is a rare benign mesenchymal lesion,which was first described in 1997 by Nucci et al.1 In previous reports, it has occurred mainly in the superficial soft tissue of the genital region, such as the scrotum, perinea
期刊
Establishment of two new predictive models for prostate cancer to determine whether to require prost
Our goal was to establish two new predictive models of prostate cancer to determine whether to require a prostate biopsy when the prostate-specific antigen level is in the diagnostic gray zone.A retrospective analysis of 197 patients undergoing prostate b
Prospective validation of ％p2PSA and the Prostate Health Index, in prostate cancer detection in init
Despite its widespread use for prostate cancer screening,low specificity makes PSA a suboptimal biomarker,especially in the diagnostic “gray zone” of 4-10 ng ml-1.False-positives lead to unnecessary biopsies with attendant morbidities.This is the first pr